Both are once-weekly subcutaneous injections with similar titration schedules designed to reduce nausea
Following this, we customize a maintenance schedule, which might include treatments once a month or every few weeks, based on your response to the therapy and your long-term health objectives
Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death
59 : 521528 Brown SL, Salive ME, Harris TB, Simonsick EM, Guralnik JM, Kohout FJ
This outcome reflects both the inherent difficulty of treating Alzheimer's disease and questions about whether a single neuroprotective mechanism, without addressing amyloid and tau pathology more directly, can be sufficient